Observational studyESMO open2025

Real-world evaluation of interstitial lung disease/pneumonitis in patients treated with trastuzumab deruxtecan for HER2-positive advanced or recurrent gastric cancer: a postmarketing surveillance study in Japan.

H Kawakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.